Humanoid Robot Enters Operating Room

A five-foot-tall humanoid robot just removed a gallbladder in a live surgery on a pig, raising huge questions about who will be holding the scalpel in operating rooms.

Story Snapshot

UC San Diego surgeons used teleoperated humanoid robots to complete two live gallbladder surgeries in pigs, a world-first preclinical trial.
The robot system, nicknamed Surgie, is small and light, designed to fit into normal operating rooms and even remote clinics.
One surgery paired a human surgeon with a robot; the other used two robots working together, showing both teamwork and robot-only setups.
The breakthrough could expand access to surgery in rural and under-served areas, but also deepens public worries about elite tech reshaping health care without fixing core system failures.

Humanoid robots step into the operating room

Surgeons and engineers at the University of California San Diego report that teleoperated humanoid robots have successfully performed two live laparoscopic gallbladder removals on pigs during a preclinical trial, which they describe as a world first. These procedures, called cholecystectomies, are common in human patients today and are often done with traditional robotic systems or manual tools. Using humanoid robots for this standard surgery shows the machines can work inside real bodies, not just on practice models.

The robots used in the trial are nicknamed Surgie and are built as general-purpose humanoid bodies adapted for surgery work. Each robot stands about five feet tall and weighs around sixty pounds, with human-like arms designed to hold laparoscopic instruments in tight spaces. Unlike massive surgical consoles that need special rooms, these smaller robots can fit beside the operating table like a human assistant. That size difference matters in older hospitals and rural clinics that cannot afford or house large robotic systems.

How the trial worked and what “world first” really means

The UC San Diego team ran two different setups to test the technology’s limits, both under direct surgeon control. In one surgery, a human surgeon worked side by side with a single humanoid robot, adjusting its arms and guiding the procedure as a bedside partner. In the second, two humanoid robots worked together to complete a laparoscopic gallbladder removal, with no other humans physically in the operating space. Surgeons controlled the robots through teleoperation, meaning the robots moved based on human commands rather than acting on their own.

Researchers and media outlets have framed these operations as a “historic” and “world-first” milestone, and the core facts support that claim: no previous study has documented humanoid robots performing live internal surgery in animals this way. Still, this is a preclinical proof of concept, not regular medical care. The trial involved only two pigs, which means there is no strong data yet on long-term safety, complication rates, or how the system handles unexpected events. Calling this a full revolution now risks confusing the public about how far the technology has really come.

Promise for rural care and the deep state of health systems

UC San Diego’s team emphasizes that Surgie’s compact size and teleoperated design could help patients in remote or under-resourced areas who currently lack access to skilled surgeons. Because the robots are small and relatively light, they might be shipped or driven into small clinics where a human surgeon then operates them from afar using a secure link. For Americans who live hours from a major hospital and feel forgotten by coastal elites and federal planners, this idea of robot-extended care sounds like a rare sign that technology might actually reach them.

At the same time, the news lands in a country where many citizens on both the right and the left already believe the health system serves insurance companies, hospital chains, and tech investors more than patients. People have watched costs climb, networks narrow, and rural hospitals close, while government agencies and lawmakers argued and postured. When they hear “humanoid robots will do your surgery,” many wonder who will really benefit: the patient in the small town, or the university and companies that license and sell the machines. That distrust shapes how this breakthrough will be received.

Risks, regulation, and fears of a robot-run future

Despite the headlines, Surgie is not ready to operate on human patients. The researchers describe the work as a preclinical trial, and any move to human use would have to pass through strict United States Food and Drug Administration approval steps designed for new surgical robots. Past experience with systems like the da Vinci robot shows that only a fraction of experimental platforms ever make it to wide clinical use, and that process can take years. Regulators will want detailed data on errors, response to emergencies, and what happens if network links fail during surgery.

Incredible robotics resarch award of the day goes to: UC San Diego for performing surgery on a live pig using a humanoid robot (Unitree G1).

Accuracy of this approach is indistinguishable to using a da Vinci surgery robots worth several millions of dollars.
Only caveat: 2x… pic.twitter.com/1d3W7hjm0q

— Léo (@LeoKharon) July 10, 2026

Humanoid robots also face a public image problem. For years, many people saw them mainly in videos doing backflips, dancing, or acting in theme parks, which made them look like entertainment devices rather than trusted medical tools. Now the same style of robot appears in an operating room, with a pig on the table and surgeons at the controls. Some Americans hear “AI” and “robot surgeon” and worry that decisions will be made by opaque algorithms and distant elites, not by someone who knows their name and community.

What this means for everyday Americans watching Washington

This breakthrough comes as many Americans feel that both major parties and the federal government have failed to fix basic health problems like insurance costs, doctor shortages, and hospital closures. While Congress argues over budgets and culture war issues, university labs and private companies are quietly building tools that might reshape medicine without strong public input. The Surgie trial is a clear example: a major leap in surgical technology happened in a lab, then was announced with “world-first” headlines, but ordinary citizens had no say in how, where, or why it was tested.

If humanoid surgeons become common, they could help people in distant towns get lifesaving operations from top doctors without leaving home. They could also deepen a system where care depends on expensive machines controlled by a small group of experts, companies, and regulators. For readers who already feel that a “deep state” of elites runs policy, this news may look like both hope and warning at the same time: proof that American ingenuity is still alive, and a reminder that without real oversight and public voice, even amazing tools can widen the gap between the haves and the have-nots.